ag 1879 has been researched along with Benign Neoplasms in 6 studies
3-(4-chlorophenyl)-1-(1,1-dimethylethyl)-1H-pyrazolo(3,4-d)pyrimidin-4-amine: Fyn kinase inhibitor
| Excerpt | Relevance | Reference |
|---|---|---|
| "Enhanced angiogenesis is present in tumors that need new blood capillaries to grow, remove metabolic waste and transport the cells to locations distal to the primary tumor, facilitating metastasis formation." | 2.44 | SRC inhibitors and angiogenesis. ( Botta, M; Manetti, F; Schenone, S, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Zeng, LF | 1 |
| Wang, Y | 2 |
| Kazemi, R | 1 |
| Xu, S | 1 |
| Xu, ZL | 1 |
| Sanchez, TW | 1 |
| Yang, LM | 1 |
| Debnath, B | 1 |
| Odde, S | 1 |
| Xie, H | 1 |
| Zheng, YT | 1 |
| Ding, J | 1 |
| Neamati, N | 1 |
| Long, YQ | 1 |
| Chauhan, M | 1 |
| Kumar, R | 1 |
| Maruta, H | 1 |
| Ahn, MR | 1 |
| Manolache, A | 1 |
| Selescu, T | 1 |
| Maier, GL | 1 |
| Mentel, M | 1 |
| Ionescu, AE | 1 |
| Neacsu, C | 1 |
| Babes, A | 1 |
| Szedlacsek, SE | 1 |
| Dalgarno, D | 1 |
| Stehle, T | 1 |
| Narula, S | 1 |
| Schelling, P | 1 |
| van Schravendijk, MR | 1 |
| Adams, S | 1 |
| Andrade, L | 1 |
| Keats, J | 1 |
| Ram, M | 1 |
| Jin, L | 1 |
| Grossman, T | 1 |
| MacNeil, I | 1 |
| Metcalf, C | 1 |
| Shakespeare, W | 1 |
| Keenan, T | 1 |
| Sundaramoorthi, R | 1 |
| Bohacek, R | 1 |
| Weigele, M | 1 |
| Sawyer, T | 1 |
| Schenone, S | 1 |
| Manetti, F | 1 |
| Botta, M | 1 |
3 reviews available for ag 1879 and Benign Neoplasms
| Article | Year |
|---|---|
Medicinal attributes of pyrazolo[3,4-d]pyrimidines: a review.
Topics: Adenosine Deaminase Inhibitors; Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Antineopla | 2013 |
From bench (laboratory) to bed (hospital/home): How to explore effective natural and synthetic PAK1-blockers/longevity-promoters for cancer therapy.
Topics: Animals; Antineoplastic Agents; Click Chemistry; Drug Discovery; Humans; Longevity; Neoplasms; p21-A | 2017 |
SRC inhibitors and angiogenesis.
Topics: Angiogenesis Inhibitors; Animals; Humans; Neoplasms; Neovascularization, Physiologic; Protein Kinase | 2007 |
3 other studies available for ag 1879 and Benign Neoplasms
| Article | Year |
|---|---|
Repositioning HIV-1 integrase inhibitors for cancer therapeutics: 1,6-naphthyridine-7-carboxamide as a promising scaffold with drug-like properties.
Topics: Antineoplastic Agents; Drug Design; HIV Infections; HIV Integrase; HIV Integrase Inhibitors; HIV-1; | 2012 |
Regulation of TRPM8 channel activity by Src-mediated tyrosine phosphorylation.
Topics: Animals; Biological Transport; Cold Temperature; Ganglia, Spinal; HEK293 Cells; Humans; Inflammation | 2020 |
Structural basis of Src tyrosine kinase inhibition with a new class of potent and selective trisubstituted purine-based compounds.
Topics: Adenine; Adenosine Triphosphate; Bone and Bones; Carbon; Catalytic Domain; Cyclin-Dependent Kinase 2 | 2006 |